FORT COLLINS, Colo., Sept. 21, 2021 /PRNewswire/ -- Statera Biopharma, Inc. (Nasdaq: STAB), a leading biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, will participate in the 2021 Cantor Virtual Global Healthcare Conference taking place September 27-30, 2001. Michael K. Handley, President and Chief Executive Officer of Statera, will participate in a virtual fireside chat on Thursday, September 30, 2021.
- A webcast of the discussion will be available on the Investor Relations section of the Statera website following the conference.
- Investors who wish to register for the conference should contact their Cantor Fitzgerald sales representative.
- The company announced its new corporate name, Statera BioPharma, on August 31, 2021.
- Statera has clinicalprograms for Crohn's disease (STAT-201),hematology (Entolimod), pancreatic cancer (STAT-401) andCOVID-19 (STAT-205) in addition to expansion into fibromyalgia and multiple sclerosis.To learn more about Statera Biopharma, please visit www.staterabiopharma.com .